BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 26388768)

  • 1. Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia.
    Benussi A; Padovani A; Borroni B
    Front Aging Neurosci; 2015; 7():171. PubMed ID: 26388768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinic, neuropathology and molecular genetics of frontotemporal dementia: a mini-review.
    Pan XD; Chen XC
    Transl Neurodegener; 2013 Apr; 2(1):8. PubMed ID: 23597030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.
    Seltman RE; Matthews BR
    CNS Drugs; 2012 Oct; 26(10):841-70. PubMed ID: 22950490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Genetics of Monogenic Frontotemporal Dementia.
    Takada LT
    Dement Neuropsychol; 2015; 9(3):219-229. PubMed ID: 29213965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinsonian syndrome in familial frontotemporal dementia.
    Siuda J; Fujioka S; Wszolek ZK
    Parkinsonism Relat Disord; 2014 Sep; 20(9):957-64. PubMed ID: 24998994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary progressive aphasia and the FTD-MND spectrum disorders: clinical, pathological, and neuroimaging correlates.
    Vinceti G; Olney N; Mandelli ML; Spina S; Hubbard HI; Santos-Santos MA; Watson C; Miller ZA; Lomen-Hoerth C; Nichelli P; Miller BL; Grinberg LT; Seeley WW; Gorno-Tempini ML
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):146-158. PubMed ID: 30668155
    [No Abstract]   [Full Text] [Related]  

  • 7. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features.
    Mahoney CJ; Beck J; Rohrer JD; Lashley T; Mok K; Shakespeare T; Yeatman T; Warrington EK; Schott JM; Fox NC; Rossor MN; Hardy J; Collinge J; Revesz T; Mead S; Warren JD
    Brain; 2012 Mar; 135(Pt 3):736-50. PubMed ID: 22366791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New perspective on parkinsonism in frontotemporal lobar degeneration.
    Park HK; Chung SJ
    J Mov Disord; 2013 May; 6(1):1-8. PubMed ID: 24868417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontotemporal Dementia.
    Olney NT; Spina S; Miller BL
    Neurol Clin; 2017 May; 35(2):339-374. PubMed ID: 28410663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.
    Cairns NJ; Bigio EH; Mackenzie IR; Neumann M; Lee VM; Hatanpaa KJ; White CL; Schneider JA; Grinberg LT; Halliday G; Duyckaerts C; Lowe JS; Holm IE; Tolnay M; Okamoto K; Yokoo H; Murayama S; Woulfe J; Munoz DG; Dickson DW; Ince PG; Trojanowski JQ; Mann DM;
    Acta Neuropathol; 2007 Jul; 114(1):5-22. PubMed ID: 17579875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biological phenotypes of frontotemporal dementia: Perspectives for disease modifying therapies.
    Gazzina S; Manes MA; Padovani A; Borroni B
    Eur J Pharmacol; 2017 Dec; 817():76-85. PubMed ID: 28579383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical parkinsonian syndromes: a general neurologist's perspective.
    Deutschländer AB; Ross OA; Dickson DW; Wszolek ZK
    Eur J Neurol; 2018 Jan; 25(1):41-58. PubMed ID: 28803444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes.
    Murley AG; Coyle-Gilchrist I; Rouse MA; Jones PS; Li W; Wiggins J; Lansdall C; RodrĂ­guez PV; Wilcox A; Tsvetanov KA; Patterson K; Lambon Ralph MA; Rowe JB
    Brain; 2020 May; 143(5):1555-1571. PubMed ID: 32438414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontotemporal lobar degeneration: a clinical approach.
    Karageorgiou E; Miller BL
    Semin Neurol; 2014 Apr; 34(2):189-201. PubMed ID: 24963678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum.
    Meeter LHH; Vijverberg EG; Del Campo M; Rozemuller AJM; Donker Kaat L; de Jong FJ; van der Flier WM; Teunissen CE; van Swieten JC; Pijnenburg YAL
    Neurology; 2018 Apr; 90(14):e1231-e1239. PubMed ID: 29514947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration.
    Rohrer JD; Lashley T; Schott JM; Warren JE; Mead S; Isaacs AM; Beck J; Hardy J; de Silva R; Warrington E; Troakes C; Al-Sarraj S; King A; Borroni B; Clarkson MJ; Ourselin S; Holton JL; Fox NC; Revesz T; Rossor MN; Warren JD
    Brain; 2011 Sep; 134(Pt 9):2565-81. PubMed ID: 21908872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
    Josephs KA; Petersen RC; Knopman DS; Boeve BF; Whitwell JL; Duffy JR; Parisi JE; Dickson DW
    Neurology; 2006 Jan; 66(1):41-8. PubMed ID: 16401843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontotemporal degeneration.
    Yener GG; Rosen HJ; Papatriantafyllou J
    Continuum (Minneap Minn); 2010 Apr; 16(2 Dementia):191-211. PubMed ID: 22810288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrafamilial phenotypic heterogeneity in a Taiwanese family with a MAPT p.R5H mutation: a case report and literature review.
    Lin HC; Lin CH; Chen PL; Cheng SJ; Chen PH
    BMC Neurol; 2017 Sep; 17(1):186. PubMed ID: 28923025
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.